As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.
As the healthcare industry moves toward population health and improving quality and value, The American Journal of Managed Care (AJMC) is in a good position to help lead the change, according to Rose Maljanian, RN, MBA, chairman and chief executive officer of HealthCAWS and a member of the AJMC editorial board.
Transcript (slightly modified for readability)
Happy anniversary to AJMC, it's an important, multi-stakeholder movement, not only a high-quality journal, and I'm so pleased to be part of the board.
How has AJMC contributed to the field of managed care over the last 20 years?
AJMC has really been the sole provider of a very broad literature on managed care real-world studies, and having been a co-founder of a delivery system-based institute for outcomes research on evaluation, I really appreciate the real-world approach to the science.
It's important to have a peer-reviewed process that includes the look at methodology and statistical approaches in a real-world setting. Not all of the studies included in this broad literature are randomized trials, and that opens up a whole world of opportunity to share best practices across the nation, and the world.
How will both managed care and AJMC change in the next 20 years?
Well I think the answer to that is for both AJMC and the industry, the movement really is toward population health, improving quality, and improving value, and that means better quality for a reasonable cost and the best value for patients, who we're now referring to as consumers. And managed care is across multi-stakeholder groups: it's payers of all kinds, it's the delivery systems involved in accountable care, and it's the consumers seeking other places of care in the retail world that are really going to require a massive change in how we look at the healthcare delivery system, and moving it more into the lives of consumers and patients.
I think the group, the board, that AJMC has put together really is in a good position to continue to support its members in a way that can lead this change.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Covered Preventive Services at Risk: V-BID Summit Breaks Down the Braidwood v Becerra Case
March 20th 2024For more than a decade, certain high-value preventive care services have been covered at no cost to patients under the Affordable Care Act, but a current legal challenge has the coverage at risk.
Read More
Reducing Low-Value Care Is Hard, but What About Just Not Paying for It?
March 14th 2024After years of efforts to reduce low-value care, panelists at the 2024 Value-Based Insurance Design Summit proposed a new strategy: drawing a line in the sand that payers will not be on the hook for these services.
Read More
Evolution of HDHPs With VBID Components Can Improve Care for Chronic Disease
March 14th 2024Over the course of the last 20 years, high-deductible health plans (HDHPs) have undergone an evolution. Today’s plans, with more high-value services covered predeductible, can improve care for people with chronic diseases, said panelists at the 2024 Value-Based Insurance Design (V-BID) Summit.
Read More